NCT02703298View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 25, 2016

Primary Completion Date

January 23, 2018

Study Completion Date

May 3, 2018

Conditions
CarcinomaAdvanced Cancer
Interventions
DRUG

TRX-818 capsules

Trial Locations (1)

704

National Cheng Kung University Hospital, Tainan City

All Listed Sponsors
lead

TaiRx, Inc.

INDUSTRY

NCT02703298 - Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients | Biotech Hunter | Biotech Hunter